Select Page



Gaëtan Gavazzi, M.D., Ph.D.


Prof. Gavazzi specializes in Geriatrics, Internal Medicine and Healthy Ageing.


Dr Gavazzi accomplished his medical school in Nantes (France) (1985-91) and moved to Grenoble (France) to be graduated in Internal Medicine (1998), and Geriatric and Infectiology (2000 and 2004). Its first postgraduate position was in Grenoble in Internal and Geriatric Medicine (1998-2000). He moved to Geneva University Hospital (2000-2005) where he developed infectiology in Geriatric medicine at the Geriatric department; he also developed it’s basic research background with a PhD thesis regarding the role NOX enzymes producing reactive oxygen species in age-related diseases in animal models. He came back to Grenoble in 2005 to take an assistant-professor position. From September 2011, he is Professor of Geriatric Medicine at the University Hospital of Grenoble-Alpes. The main topics of interest, in clinical research are still “Infection in older population”, and ageing through the “frailty syndrome”. More recently, he coordinates oncogeriatric team and, orthogeriatric and pharmacogeriatric projects at University of Grenoble-Alpes Hospital. From 2005 he joined more than 40 scientific expert groups of interest in France and in Europe and is the co- coordinator of the French National Infectiology and Geriatric Group (GInGer) and the European Study Group of Infection and vaccine SIG in Elderly of EUGMS and still member of both European Vaccine Study Group (ESVAG) and “infection in elderly groups (ESGIE) of ESCMID. He is regularly involved in expert groups (WHO, European institution such as ECDC).He published more than 120 peer reviewed papers and participate near to 500 communications at national and international levels. He is also involved in education and training at Medical school of University of Grenoble-Alpes, and is the President of the National Association of Professors of Geriatric; he keeps healthcare activities as responsible for acute care and rehabilitation for older population wards, and as coordinator of local and regional of Oncogeriatric units.


Des centaines de praticiens hospitaliers s'alarment du plan Santé

October 08, 2018

Finalement le plan ne précise pas les indicateurs sur lequel il devra être jugé : nombre de passage annuel aux urgences, délai pour trouver un lit disponible dans un service correspondant aux besoins des patients admis à l’hôpital en urgence, diminution des actes et des prescriptions injustifiés, taux d’absence du personnel soignant et taux de non-remplacement des personnels, amélioration de la qualité de vie au travail des soignants et satisfaction des patients.

Read More

Le vieillissement n’est pas une maladie
Le Dauphiné

April 17, 2018

Pr. Gaétan Gavazzi Professeur en gériatrie au CHU Grenoble Alpes, président du collège national des enseignants de gériatrie.

Read More

Nous, médecins hospitaliers et cadres de santé…

January 15, 2018

A l’appel des professeurs André Grimaldi, Jean-Paul Vernant et de la docteure Anne Gervais, ils sont mille à alerter sur la crise de l’hôpital.

Read More

Comment la grippe entre dans les maisons de retraite
Le Figaro

January 09, 2017

La grippe est une maladie fréquente et qui tue énormément, insiste aussi le Pr Gaëtan Gavazzi, professeur de gériatrie au CHU de Grenoble, c’est pourquoi la vaccination à titre collectif est très importante.

Read More

Quels vaccins après 65 ans?
Destination Sante

December 04, 2015

Plus nous avançons en âge, plus notre organisme devient sensible aux infections. D’où l’importance du rendez-vous vaccinal à partir de 65 ans. Le Pr Gaëtan Gavazzi, gériatre au CHU de Grenoble, nous explique quelles sont les maladies contre lesquelles les seniors doivent se protéger.

Read More


Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting
BMC Public Health

2019Despite the existence of efficacious vaccines, the burden of vaccine-preventable diseases remains high and the potential health benefits of paediatric, adolescent and adult vaccination are not being achieved due to suboptimal vaccine coverage rates.

Read Full Article

ATOUM 6: does a multimodal intervention involving nurses reduce the use of antibiotics in French nursing homes?: A protocol for a cluster randomized study
Medicine (Baltimore)

2019Urinary tract infection (UTI) is common in elderly living in nursing homes, and antibiotics prescription for this infection is particularly challenging. In these facilities, due to the absence of on-site physicians, nurses play an essential role when an infection is suspected, as they are the ones who collect and communicate by phone all the information needed by the physician for the decision-making process.

Read Full Article

Antimicrobial consumption and impact of Antimicrobial Stewardship programmes in long-term care facilities
Clin Microbiol Infect

2019Antimicrobials are among the most frequently prescribed drugs in long-term care facilities (LTCFs). Implementation of antimicrobial stewardship programmes (ASPs) is often challenging because of scarce data in this setting.

Read Full Article

Quadrivalent influenza vaccine: What is changed and what are the benefits?
Presse Med

2018Currently, circulating viruses responsible for annual seasonal influenza epidemics belong to two influenza A subtypes, A(H1N1) and A(H3N2), and to two antigenically distinct type B lineages, B/Yamagata and B/Victoria lineages. Like diseases due to influenza A virus, influenza B virus diseases may have severe consequences and should be prevented.

Read Full Article

Efficacy of indefinite chronic oral antimicrobial suppression for prosthetic joint infection in the elderly: a comparative study
Int J Infect Dis

2017During prosthetic joint infection (PJI), surgical management is sometimes impossible and indefinite chronic oral antimicrobial suppression (ICOAS) may be the only option. The outcomes of elderly patients who benefited from ICOAS with strictly palliative intent were evaluated.

Read Full Article



Area of Expertise


Membre du groupe Biomarker - 2019 to present

Member of the European Study Vaccine in Adult Group for European Society For Clinical microbiology and Infectious Diseases (ESCMID) - 2017 to present

Leader du SIG infectious disease in elderly (European Geriatric Medicine Society) - 2015 to present

Leader of the working group (task and finnish group) on vaccine for the European Union Of Geriatric Medicine Society - 2014 to 2015

Full Member of European Society For Clinical microbiology and Infectious Diseases (ESCMID) - 2013 to present

Membre conseil scientifique de la Société Française de Gériatrie et Gérontologie - 2013 to present

Member of the European Study Group for Infection in Elderly of European Society For Clinical microbiology and Infectious Diseases (ESCMID) - 2012 to present


Université J. Fourier Grenoble :

Université J. Fourier Grenoble :

Université Nantes :

Université J. Fourier Grenoble : Médecine

Université J. Fourier Grenoble : Médicale C2: Physiologie générale

Université J. Fourier Grenoble : Médicale C1 Méthodes en recherche clinique et épidémiologique

Share This